Form 8-K - Current report:
SEC Accession No. 0001839882-23-007387
Filing Date
2023-03-23
Accepted
2023-03-23 16:33:36
Documents
34
Period of Report
2023-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_032323.htm   iXBRL 8-K 31090
2 PRESS RELEASE ex99-01.htm EX-99.01 16753
3 TNX-2900 DATA RARE DISEASE PRESENTATION ex99-02.htm EX-99.02 28428
7 GRAPHIC tnxp-01.jpg GRAPHIC 301101
8 GRAPHIC tnxp-02.jpg GRAPHIC 276522
9 GRAPHIC tnxp-03.jpg GRAPHIC 249717
10 GRAPHIC tnxp-04.jpg GRAPHIC 232396
11 GRAPHIC tnxp-05.jpg GRAPHIC 185194
12 GRAPHIC tnxp-06.jpg GRAPHIC 178833
13 GRAPHIC tnxp-07.jpg GRAPHIC 195818
14 GRAPHIC tnxp-08.jpg GRAPHIC 135941
15 GRAPHIC tnxp-09.jpg GRAPHIC 176502
16 GRAPHIC tnxp-10.jpg GRAPHIC 206584
17 GRAPHIC tnxp-12.jpg GRAPHIC 183372
18 GRAPHIC tnxp-13.jpg GRAPHIC 186581
19 GRAPHIC tnxp-14.jpg GRAPHIC 185640
20 GRAPHIC tnxp-15.jpg GRAPHIC 190391
21 GRAPHIC tnxp-16.jpg GRAPHIC 152128
22 GRAPHIC tnxp-17.jpg GRAPHIC 184135
23 GRAPHIC tnxp-18.jpg GRAPHIC 194753
24 GRAPHIC tnxp-19.jpg GRAPHIC 191226
25 GRAPHIC tnxp-20.jpg GRAPHIC 255437
26 GRAPHIC tnxp-21.jpg GRAPHIC 131349
  Complete submission text file 0001839882-23-007387.txt   5769686

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20230323.xsd EX-101.SCH 2968
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20230323_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20230323_pre.xml EX-101.PRE 22365
28 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_032323_htm.xml XML 3747
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 23756705
SIC: 2834 Pharmaceutical Preparations